| Nanoparticles and targeted drug delivery in cancer therapy B Bahrami, M Hojjat-Farsangi, H Mohammadi, E Anvari, G Ghalamfarsa, ... Immunology letters 190, 64-83, 2017 | 517 | 2017 |
| Strategies toward rheumatoid arthritis therapy; the old and the new M Abbasi, MJ Mousavi, S Jamalzehi, R Alimohammadi, MH Bezvan, ... Journal of cellular physiology 234 (7), 10018-10031, 2019 | 365 | 2019 |
| The paradox of Th17 cell functions in tumor immunity Z Asadzadeh, H Mohammadi, E Safarzadeh, M Hemmatzadeh, ... Cellular immunology 322, 15-25, 2017 | 219 | 2017 |
| Myeloid‐derived suppressor cells: important contributors to tumor progression and metastasis E Safarzadeh, M Orangi, H Mohammadi, F Babaie, B Baradaran Journal of cellular physiology 233 (4), 3024-3036, 2018 | 171 | 2018 |
| Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer MH Kazemi, S Raoofi Mohseni, M Hojjat‐Farsangi, E Anvari, ... Journal of Cellular Physiology 233 (3), 2032-2057, 2018 | 140 | 2018 |
| The effects of cadmium exposure in the induction of inflammation N Hossein-Khannazer, G Azizi, S Eslami, H Alhassan Mohammed, ... Immunopharmacology and immunotoxicology 42 (1), 1-8, 2020 | 112 | 2020 |
| Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review S Habibi, M Zaki-Dizaji, H Rafiemanesh, B Lo, M Jamee, L Gámez-Díaz, ... The Journal of Allergy and Clinical Immunology: in Practice 7 (7), 2379-2386. e5, 2019 | 98 | 2019 |
| The role of oncomirs in the pathogenesis and treatment of breast cancer M Hemmatzadeh, H Mohammadi, F Jadidi-Niaragh, F Asghari, M Yousefi Biomedicine & Pharmacotherapy 78, 129-139, 2016 | 96 | 2016 |
| Interleukin-22 in human inflammatory diseases and viral infections AG Shabgah, JG Navashenaq, OG Shabgah, H Mohammadi, A Sahebkar Autoimmunity reviews 16 (12), 1209-1218, 2017 | 91 | 2017 |
| Overview on experimental models of interactions between nanoparticles and the immune system S Najafi-Hajivar, P Zakeri-Milani, H Mohammadi, M Niazi, ... Biomedicine & Pharmacotherapy 83, 1365-1378, 2016 | 90 | 2016 |
| The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates F Babaie, M Hasankhani, H Mohammadi, E Safarzadeh, A Rezaiemanesh, ... Immunology letters 196, 52-62, 2018 | 86 | 2018 |
| Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer E Safarzadeh, S Hashemzadeh, PHG Duijf, B Mansoori, V Khaze, ... Journal of cellular physiology 234 (4), 3515-3525, 2019 | 83 | 2019 |
| CDK1 in breast cancer: implications for theranostic potential S Izadi, A Nikkhoo, M Hojjat-Farsangi, A Namdar, G Azizi, H Mohammadi, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 81 | 2020 |
| Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer M Hemmatzadeh, H Mohammadi, M Karimi, MH Musavishenas, ... Biomedicine & Pharmacotherapy 82, 509-519, 2016 | 80 | 2016 |
| Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine H Hassannia, M Ghasemi Chaleshtari, F Atyabi, M Nosouhian, A Masjedi, ... Immunology 159 (1), 75-87, 2020 | 75 | 2020 |
| MicroRNAs: small molecules with a large impact on pre‐eclampsia M Hemmatzadeh, N Shomali, Y Yousefzadeh, H Mohammadi, ... Journal of cellular physiology 235 (4), 3235-3248, 2020 | 70 | 2020 |
| Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line H Siahmansouri, MH Somi, Z Babaloo, B Baradaran, F Jadidi-Niaragh, ... Journal of Pharmacy and Pharmacology 68 (9), 1119-1130, 2016 | 70 | 2016 |
| Approach to the management of autoimmunity in primary immunodeficiency G Azizi, V Ziaee, M Tavakol, T Alinia, R Yazdai, H Mohammadi, ... Scandinavian journal of immunology 85 (1), 13-29, 2017 | 69 | 2017 |
| Autoimmunity in primary antibody deficiencies G Azizi, M Ahmadi, H Abolhassani, R Yazdani, H Mohammadi, ... International archives of allergy and immunology 171 (3-4), 180-193, 2017 | 60 | 2017 |
| Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome M Jamee, M Zaki-Dizaji, B Lo, H Abolhassani, F Aghamahdi, M Mosavian, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2747-2760. e7, 2020 | 59 | 2020 |
